IWA
ABBV icon

Icon Wealth Advisors’s AbbVie ABBV Stock Holding History

Icon Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.9M Buy
43,276
+7,717
+22% +$1.66M 0.66% 37
2026
Q1 		$7.25M Sell
35,559
-6,948
-16% -$1.54M 0.47% 42
2025
Q4 		$9.68M Buy
42,507
+659
+2% +$150K 0.64% 36
2025
Q3 		$9.69M Sell
41,848
-842
-2% -$171K 0.66% 36
2025
Q2 		$7.92M Buy
42,690
+3,238
+8% +$602K 0.56% 36
2025
Q1 		$8.27M Buy
39,452
+107
+0.3% +$20.8K 0.68% 33
2024
Q4 		$6.99M Buy
39,345
+581
+1% +$107K 0.58% 35
2024
Q3 		$7.66M Buy
38,764
+618
+2% +$115K 0.64% 29
2024
Q2 		$7.07M Buy
38,146
+2,538
+7% +$420K 0.63% 31
2024
Q1 		$6.48M Sell
35,608
-118
-0.3% -$20.3K 0.6% 32
2023
Q4 		$5.54M Buy
+35,726
New +$5.21M 0.58% 31
2022
Q4 		$8.72M Buy
53,953
+1,780
+3% +$273K 1% 17
2022
Q3 		$7M Buy
+52,173
New +$7.49M 0.85% 19

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Icon Wealth Advisors's ABBV Position: Q2 2026 in Review

Icon Wealth Advisors increased its AbbVie (ABBV) stake by 22% in Q2 2026, buying an estimated $1.66M and bringing the position to 43,276 shares worth $10.9M. The position accounts for 0.66% of the portfolio, ranked #37.

Icon Wealth Advisors first reported a position in ABBV in Q3 2022 and has held it in 13 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Icon Wealth Advisors held 43,276 shares of AbbVie worth $10.9M as of Q2 2026.
  • Icon Wealth Advisors bought 7,717 AbbVie shares in Q2 2026, an estimated $1.66M.
  • AbbVie made up 0.66% of Icon Wealth Advisors's portfolio in Q2 2026, its #37 holding.
  • Icon Wealth Advisors first reported a position in AbbVie in Q3 2022 and has held it in 13 quarters since.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Icon Wealth Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.